In this study, five clinical datasets (more than 2500 people) were collected from the Global Alzheimer’s Association Interaction Network (GAAIN) and the association between cognitive impairment, and phosphorylated tau (p-tau) levels (or total tau levels) in cerebrospinal fluid (CSF) was assessed. This evidence concerns the gene MAPT and Cognitive impairment.